Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine

Real-world Improvements in Cognitive Symptoms After Eptinezumab Treatment in Patients in Whom =1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for the Ongoing INFUSE Study

Desensitization Protocol in Patients with Immediate Eptinezumab Hypersensitivity: A Case Series

Community Health Worker Integration into Migraine Care: A Model for Scalable Migraine Screening